Listar INIBIC-ECAPE - Artigos por autor "Marín, Francisco"

Mostrando ítems 1-10 de 10

    • Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry 

      Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Raña-Míguez, Paula; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory; Marín, Francisco (NLM, 2019-12-24)
      [Abstract] Background. Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ...

    • Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study 

      Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)
      [Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...

    • Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores 

      Esteve-Pastor, María Asunción; Marín, Francisco; Bertomeu-Martínez, Vicente; Roldán, Inmaculada; Cequier, Ángel; Badimón, Lina; Muñiz, Javier; Valdés, Mariano; Anguita, Manuel (Wiley, 2016-03-01)
      [Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF). AIM: The aim of this study is to assess concordance ...

    • Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study 

      Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Ruiz Ortiz, Martín; Marín, Francisco; Roldán, Vanessa; Quesada, María Angustias; Camacho Siles, José; Cequier Fillat, Angel; Bertomeu-Martínez, Vicente; Martínez-Sellés, Manuel; Badimón, Lina (Elsevier, 2020-04-14)
      [Abstract] Background: While many risk factors for Atrial Fibrillation (AF) have been identified, there are important differences in their relative impact between sexes. The aim of our study was to investigate the influence ...

    • La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K 

      Anguita-Sánchez, Manuel; Anguita Gámez, María; Bertomeu, Vicente; Ruiz Ortiz, Martín; Cequier, Ángel; Roldán, Inmaculada; Muñiz, Javier; Esteve-Pastor, María Asunción; Vivas Balcones, David; Marín, Francisco; Pérez-Villascastín, Julián (Elsevier, 2020-07)
      [Resumen] Introducción y objetivos. La fibrilación auricular tiene un mal pronóstico asociado fundamentalmente al desarrollo de ictus. A pesar del uso de anticoagulantes, algunos pacientes pueden sufrir ictus y también ...

    • Oral anticoagulation in octogenarians with atrial fibrillation 

      González Saldivar, Hugo; Figueiras-Graillet, Lourdes M.; Anguita, Manuel; Marín, Francisco; Bertomeu, Vicente; Roldán, Inmaculada; Ruiz, Martín; Muñiz, Javier; Martínez-Sellés, Manuel (Elsevier, 2016-08-08)
      [Abstract] Background. Vitamin K antagonists (VKAs) are still largely employed, even in nonvalvular atrial fibrillation (AF). Our aim was to study the clinical profile of octogenarians treated with oral anticoagulation ...

    • Quality of anticoagulation with vitamin K antagonists 

      Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)
      [Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...

    • Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: data from FANTASIIA Registry 

      Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Camacho Siles, José; Quesada, María Angustias; Ruiz Ortiz, Martín; Marín, Francisco; Martínez-Sellés, Manuel; Bertomeu, Vicente; Lip, Gregory; Cequier Fillat, Angel; Badimón, Lina (Wiley, 2018-02-09)
      [Abstract] Background. Anticoagulation control in patients with atrial fibrillation (AF) has a multidisciplinary approach although is usually managed by general practitioners (GP) or haematologists. The aim of our study ...

    • Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry 

      García-Fernández, Amaya; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu- Martínez, Vicente; Badimón, Lina; Otero, Déborah; Anguita, Manuel; Lip, Gregory; Marín, Francisco (Taylor & Francis Group, 2020-06-17)
      [Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ...

    • Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation 

      Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)
      [Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...